More than 75% of U.S. opioid treatment programs increased take-home methadone after 2024 rule change
Two years after a 2024 federal rule change, more than 75% of U.S. opioid treatment programs have provided more take-home methadone to patients. The figure is a national self-report from an industry group and is based on an estimate of the roughly 2,000 programs in the country. The shift is partial and some programs remain cautious, and questions remain about how much practice has actually changed.
Why it matters
This responds to the problem of restrictive access to a proven treatment for opioid use disorder, and the widespread adoption suggests a significant shift in clinical practice following the policy change.
CHECKED · 1 SOURCE · UNCORROBORATED
← All news